Baupost Group
13F Holdings and Portfolio Analysis
Seth Klarman 2017 Q1 13F holdings, quarterly changes, portfolio value trend and position weight distribution.
Baupost Group Overview
Baupost Group held 43 stocks in 2017 Q1, with total market value around $8.49B.
Baupost Group's top five holdings in 2017 Q1: CHENIERE ENERGY INC 12.09%, VIASAT INC(VSAT) 9.89%, TWENTY FIRST CENTY FOX INC CL A(FOXA) 7.30%, COLONY NORTHSTAR INC 7.28%, Synchrony Financial(SYF) 7.13%.
- Portfolio Value
- $8.49B
- Current Holdings
- 43 stocks
- New / Increased
- 5 / 2
- Reduced / Exited
- 8 / 6
Current Holdings
| 1 | CHENIERE ENERGY INCCUSIP 16411R208 | 1.03 | 12.09% | 21.73 - | $47.27 | - | $42.98 | 0.00 | 3.25 | +$0.09B+9.99% | Held |
| 2 | VIASAT INCVSAT | 0.84 | 9.89% | 13.16 - | $63.82 | - | $70.54 | 0.00 | 4.00 | -$0.09B-9.52% | Held |
| 3 | TWENTY FIRST CENTY FOX INC CL AFOXA | 0.62 | 7.30% | 19.14 - | $32.39 | - | $26.77 | 0.00 | 1.75 | +$0.11B+20.97% | Held |
| 4 | COLONY NORTHSTAR INCCUSIP 19625W104 | 0.62 | 7.28% | 47.91 | $12.91 | - | $12.91 | +47.91 | 0.25 | $0.00B0.00% | New |
| 5 | Synchrony FinancialSYF | 0.61 | 7.13% | 17.66 -14.52% | $34.30 | $72.84 +112.36% | $29.24 | -3.00 | 0.75 | +$0.77B+149.11% | Reduced |
| 6 | ALLERGAN PFD CONV SER ACUSIP G0177J108 | 0.58 | 6.84% | 2.43 -29.13% | $238.92 | - | $354.00 | -1.00 | 1.25 | -$0.28B-32.51% | Reduced |
| 7 | QORVO INCCUSIP 74736K101 | 0.49 | 5.80% | 7.19 | $68.56 | - | $68.56 | +7.19 | 0.25 | $0.00B0.00% | New |
| 8 | DELL TECHNOLOGIES INCCUSIP 24703L103 | 0.36 | 4.26% | 5.65 -15.03% | $64.08 | - | $47.80 | -1.00 | 0.75 | +$0.09B+34.06% | Reduced |
| 9 | PBF ENERGY INCCUSIP 69318G106 | 0.35 | 4.10% | 15.72 - | $22.17 | - | $25.23 | 0.00 | 3.75 | -$0.05B-12.14% | Held |
| 10 | THERAVANCE BIOPHARMA INCCUSIP G8807B106 | 0.34 | 4.02% | 9.27 - | $36.82 | - | $30.34 | 0.00 | 3.00 | +$0.06B+21.37% | Held |
| 11 | ANTERO RES CORPCUSIP 03674X106 | 0.33 | 3.90% | 14.51 - | $22.81 | - | $13.71 | 0.00 | 2.75 | +$0.13B+66.36% | Held |
| 12 | QUALCOMM IncorporatedQCOM | 0.30 | 3.52% | 5.22 | $57.34 | $163.45 +185.05% | $57.34 | +5.22 | 0.25 | +$0.55B+185.05% | New |
| 13 | TWENTY FIRST CENTY FOX INC CL BCUSIP 90130A200 | 0.23 | 2.72% | 7.28 - | $31.78 | - | $27.19 | 0.00 | 1.75 | +$0.03B+16.90% | Held |
| 14 | INNOVIVA INCCUSIP 45781M101 | 0.16 | 1.88% | 11.57 -22.49% | $13.83 | - | $12.59 | -3.36 | 1.25 | +$0.01B+9.85% | Reduced |
| 15 | KERYX BIOPHARMACEUTICALS INCCUSIP 492515101 | 0.16 | 1.87% | 25.79 - | $6.16 | - | $14.16 | 0.00 | 3.25 | -$0.21B-56.50% | Held |
| 16 | VERITIV CORPCUSIP 923454102 | 0.16 | 1.86% | 3.04 - | $51.80 | - | $46.74 | 0.00 | 2.75 | +$0.02B+10.84% | Held |
| 17 | MCKESSON CORP COMMCK | 0.15 | 1.75% | 1.00 - | $148.26 | $742.44 +400.77% | $140.45 | 0.00 | 0.50 | +$0.60B+428.62% | Held |
| 18 | FORWARD PHARMA A/SCUSIP 34986J105 | 0.12 | 1.41% | 5.58 +3.88% | $21.51 | - | $20.86 | +0.21 | 2.50 | +$0.00B+3.14% | Increased |
| 19 | ATARA BIOTHERAPEUTICS INCCUSIP 046513107 | 0.11 | 1.30% | 5.36 - | $20.55 | - | $31.84 | 0.00 | 2.50 | -$0.06B-35.46% | Held |
| 20 | CARDINAL HEALTH INCCAH | 0.08 | 0.99% | 1.03 - | $81.55 | - | $71.97 | 0.00 | 0.50 | +$0.01B+13.31% | Held |
| 21 | EXPRESS SCRIPTS HLDG CO COMESRX | 0.08 | 0.95% | 1.23 | $65.91 | - | $65.91 | +1.23 | 0.25 | $0.00B0.00% | New |
| 22 | SILVER RUN ACQUISITIONCUSIP 82812A202 | 0.07 | 0.81% | 6.62 | $10.43 | - | $10.43 | +6.62 | 0.25 | $0.00B0.00% | New |
| 23 | LIBERTY VENTURES COMMON STOCKCUSIP 53071M856 | 0.07 | 0.78% | 1.48 - | $44.48 | - | $36.87 | 0.00 | 0.50 | +$0.01B+20.64% | Held |
| 24 | CHIPMOS TECHNOLOGIES INCCUSIP 16965P103 | 0.06 | 0.73% | 3.51 - | $17.75 | - | $14.11 | 0.00 | 0.50 | +$0.01B+25.80% | Held |
| 25 | CREDIT ACCEP CORP MICH COMCACC | 0.05 | 0.57% | 0.24 - | $199.41 | - | $204.24 | 0.00 | 1.00 | -$0.00B-2.36% | Held |
Showing 1-25 of 43
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.
Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.
Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.
Exited Holdings
Stocks no longer disclosed in the current 13F portfolio for 2017 Q1.
| 1 | NORTHSTAR ASSET MGMT GROUP ICUSIP 66705Y104 | 18.70 | 0.50 | $13.87 | $14.92 | +$0.02B+7.61% |
| 2 | NORTHSTAR RLTY FIN CORPCUSIP 66704R803 | 14.58 | 0.50 | $14.40 | $15.15 | +$0.01B+5.18% |
| 3 | COLONY CAP INCCUSIP 19624R106 | 6.96 | 0.50 | $18.96 | $20.25 | +$0.01B+6.81% |
| 4 | LIBERTY MEDIA CORP DELAWARECUSIP 531229706 | 0.80 | 0.75 | $15.04 | $20.49 | +$0.00B+36.24% |
| 5 | LIBERTY EXPEDIA HOLDINGS INC COMMON STOCKCUSIP 53046P109 | 0.40 | 0.25 | $39.67 | $39.67 | $0.00B0.00% |
| 6 | CITIGROUP INCCUSIP 172967226 | 62.90 | 3.75 | $1.12 | $0.15 | -$0.06B-86.46% |
Showing 1-6 of 6
Exited holdings are stocks disclosed in the previous report period but no longer disclosed in the current 13F portfolio.
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis uses the same weighted cost-pool method as current holdings. Estimated exit price uses the current report period weighted report price when available, otherwise the previous report price; it does not represent the actual sale price.
Exit return shows estimated dollar return on top and percentage return below.
Portfolio Visuals
Track portfolio value, position weights and Top 10 history.